Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04520802
Other study ID # NL.57785.091.16
Secondary ID 2016-002016-40CM
Status Completed
Phase
First received
Last updated
Start date February 18, 2019
Est. completion date July 1, 2022

Study information

Verified date March 2023
Source Radboud University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Major cardiovascular surgery is associated with postoperative cognitive decline (POCD), with a deterioration in memory, attention and speed of information processing. A multifactorial pathophysiology is presumed but this study focuses on the role of (neuro)inflammation in the development of POCD after coronary artery bypass grafting (CABG) surgery.


Description:

Systemic inflammation can activate the innate immune cells of the brain inducing neuroinflammation, which plays an important role in the pathogenesis of neurodegenerative disease. Major cardiovascular surgery induces a severe systemic inflammatory response.There is growing support that neuroinflammation is a pivotal factor in the development of postoperative cognitive decline (POCD) due to surgery-related systemic inflammation. Although the neuroinflammatory hypothesis is scientifically accepted, in vivo human data supporting the role of neuroinflammation in severe systemic inflammation such as major surgery are still lacking. In the last decades, several nuclear imaging tracers have been developed that can quantitatively measure microglial and astrocytic activation in vivo, by targeting the mitochondrial 18kDa translocator protein (TSPO). The investigators hypothesize that cardiac surgery induces a neuroinflammatory response and that its presence is related to acute and long term brain dysfunction postoperatively. This will be studied by pre- and postoperative PET brain imaging using a 18F-DPA-714 tracer targeting TSPO, combined with longitudinal neuropsychological examinations. Structural changes in the brain will be recorded on MRI prior to and after cardiac surgery to enable us to correct for the potentially confounding effects of neurovascular events on cognitive outcomes after CABG surgery.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date July 1, 2022
Est. primary completion date July 1, 2022
Accepts healthy volunteers
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Age > 50 years - Planned for on-pump coronary artery bypass grafting surgery - High-affinity binder or mixed-affinity binders based on rs6971 polymorphism for TSPO - Chronic use of statins (defined as pre-hospital use) Exclusion Criteria: - Previous cardiac surgery. - Pregnancy or wish to become pregnant within 2 weeks after PET-CT scan - Contra-indication to undergo a PET/CT or MRI scan, including claustrophobia. - Low-affinity binder based on rs6971 polymorphism for TSPO, or unable to determine rs6971 polymorphism. - Patients with cognitive disorders that have not recovered enough to be able to understand the study leaflets and information for participation. - Brain or spinal surgery within the last 6 months. - Meningitis or brain infection within the last 6 months. - Pre-existing dementia or neurodegenerative disease or cognitive impairment interfering with the ability to understand informational material about this research project. - Presence of a CSF catheter or shunt. - Patients with known brain tumors. - Patients with brain injury (e.g. acute stroke, or subarachnoid hemorrhage) within the last 6 months. - Severe brain trauma in previous medical history. - Chronic (>2 weeks) use of immunosuppressive agents (see table 3.3.A). - Concomitant diseases resulting in severe immunosuppression (e.g. HIV). - Auto-immune or auto-inflammatory disease - Active infection < 2 weeks prior to inclusion (defined as fever >38.5 or antibiotic treatment) - Kidney failure, defined by a MDRD-GFR<15 ml/min/1.73m2 - Known contrast allergy for gadolinium - Chronic use of neuroleptics, defined as pre-hospital use. - Patients that do not speak Dutch or have disabilities that prevent accurate delirium diagnosis. - Analphabetic patients. - No written informed consent obtained.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
18F-DPA-714 PET/CT neuroimaging
Pre- and postoperative neuroimaging using 18F-DPA-714 PET/CT and brain MRI. Longitudinal neuropsychological examinations (up to 6 months postoperatively) Blood samples are drawn to assess the severity of the systemic inflammatory response

Locations

Country Name City State
Netherlands Department of Intensive Care Medicine, Radboud university medical center Nijmegen

Sponsors (1)

Lead Sponsor Collaborator
Radboud University Medical Center

Country where clinical trial is conducted

Netherlands, 

References & Publications (1)

Peters van Ton AM, Duindam HB, van Tuijl J, Li WW, Dieker HJ, Riksen NP, Meijer FA, Kessels RP, Kohn N, van der Hoeven JG, Pickkers P, Rijpkema M, Abdo WF. Neuroinflammation in cognitive decline post-cardiac surgery (the FOCUS study): an observational study protocol. BMJ Open. 2021 May 11;11(5):e044062. doi: 10.1136/bmjopen-2020-044062. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in TSPO PET tracer uptake at 3-7 days post-surgery 18F-DPA-714 3-7 days post-surgery minus preoperative (= day before surgery)
Secondary Occurrence of postoperative cognitive dysfunction (POCD) POCD diagnosis based on neuropsychological assessments including TMT A&B, Stroop I, II, III, WAIS-IV - digit span, LDST, RAVLT, RCFT, RBMT-3 face recognition, LFT and token test. POCD diagnosis is made when patients are newly impaired in one or more cognitive domains (memory, executive functioning, speed of processing and language), or when the average test rating has declined in more than one domain compared to baseline. Baseline (preoperative), postoperative (3-7 days after surgery, 6 weeks and 6 months)
Secondary Whole brain TSPO PET tracer uptake pre- and 3-7 days post-surgery 18F-DPA-714 pre- and 3-7 days post-surgery
Secondary Pro- and anti-inflammatory in vivo cytokine concentrations [in pg/ml] TNFa, IL6, IL-1B, IL10, IL-1RA Day before surgery, during surgery (stop extracorporeal circulation (ECC)), after surgery (6 hours after stop ECC, 24 hours after incision, 3-7 days post-surgery and 6 weeks after surgery)
Secondary Ex vivo cytokine production of stimulated monocytes [in ng/10^9 monocytes] TNFa, IL6, IL1B, MCP1, IL10 Day before surgery, 3-7 days and 6 weeks after surgery
Secondary Flowcytometry analysis to study the inflammatory phenotype of the cells HLA-DR, CCR2, CD11b, CD14, CD16 Day before surgery, 3-7 days and 6 weeks after surgery
Secondary Complete blood count including leukocyte differentiation measured on an automated hematology analyzer Day before surgery, during surgery (stop extracorporeal circulation (ECC)), after surgery (6 hours after stop ECC, 24 hours after incision, 3-7 days post-surgery and 6 weeks after surgery)
Secondary Ex vivo cytokine production of healthy donor monocytes, after exposure to patient serum obtained during CABG surgery Healthy donor monocytes will be exposed to patient serum obtained during surgery, to see whether this changes the ex vivo cytokine producing capacity (TNFa, IL6, IL10) Perioperatively at stop extracorporeal circulation (ECC)
Secondary Number of newly developed (ischemic and hemorrhagic) brain and vascular wall lesions pre- and 3-7 days post-surgery
Secondary Delta brain activity in three large scale brain networks involved in stress reactivity on resting-state fMRI pre- and 3-7 days post-surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A